EMP displays multilayered changes to directly affect CD8+ T mediated killing, such as decreased tumor antigen, antigen presentation machinery, deficiency of IFN-γ signaling and increased immune checkpoints or indirectly by modifying the immunosuppressive microenvironment. This evidence concerns the gene CD8A and neoplasm.